MicroRNA-196a Is a Putative Diagnostic Biomarker and Therapeutic Target for Laryngeal Cancer

Koichiro Saito, Koji Inagaki, Takahiro Kamimoto, +10

PLoS ONE

Sentinel Node Concept in Clinically N0 Laryngeal and Hypopharyngeal Cancer

Masayuki Tomifuji, Akihiro Shiotani, Hirofumi Fujii, +6

Annals of Surgical Oncology

Surgical OncologyMedicineSentinel Node ConceptPathologyLarynx +7

Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities

Koji Inagaki, Tomohiro Oda, Yuichi Naka, +3

Blood

Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Schönlein purpura nephritis: a multicenter retrospective cohort study

Koji Inagaki, Ahmad Baseer Kaihan, Asaka Hachiya, +5

BMC Nephrology

Bach1 Deficiency Ameliorates Hepatic Injury in a Mouse Model

Akio Iida, Koji Inagaki, Akira Miyazaki, +3

The Tohoku Journal of Experimental Medicine

Production and characteristics of some new β-agarases from a marine bacterium, Vibrio sp. strain JT0107

Yasushi Sugano, Hideki Nagae, Koji Inagaki, +3

Journal of Fermentation and Bioengineering

Marine BiotechnologyVibrio SpEngineeringNew β-AgarasesBacteriology +3

The association between body mass index and all-cause mortality in Japanese patients with incident hemodialysis

Koji Inagaki, Naoto Tawada, Masahiro Takanashi, +1

PLoS ONE

Discovery of a novel azetidine scaffold for colony stimulating factor-1 receptor (CSF-1R) Type II inhibitors by the use of docking models

Kazutaka Ikegashira, Taku Ikenogami, Takayuki Yamasaki, +7

Bioorganic & Medicinal Chemistry Letters

Molecular DockingNovel Azetidine ScaffoldMedicinal ChemistryDrug TargetType Ii Inhibitors +10

Successful Treatment of Peritoneal Dialysis-related Peritonitis due to <i>Mycobacterium iranicum</i>

Koji Inagaki, Makoto Mizutani, Yasuko Nagahara, +6

Internal Medicine

Pulmonary TuberculosisMicrobial DiseaseMycobacterium IranicumAntibioticsPeritoneal Dialysis +6

Pharmacological Properties of JTE-952, an Orally Available and Selective Colony Stimulating Factor 1 Receptor Kinase Inhibitor

Naofumi Uesato, Naoki Miyagawa, Koji Inagaki, +7

Biological and Pharmaceutical Bulletin

ImmunologyMarked Inhibitory ActivityPharmacotherapySignaling PathwayReceptor Tyrosine Kinase +15